Tags

Type your tag names separated by a space and hit enter

Possible involvement of the interaction of the alpha 5 subunit of alpha 5 beta 1 integrin with the synergistic region of the central cell-binding domain of fibronectin in cells to fibronectin binding.
Exp Cell Res. 1995 Jan; 216(1):273-6.EC

Abstract

The interaction between the central cell-binding domain (CBD) of fibronectin (FN) and its receptor integrin alpha 5 beta 1 was analyzed by both ligand-binding and cell adhesion assays. The ligands used were a CBD fragment (pCBD) of human plasma fibronectin and its recombinant versions including wild type CBD (wtCBD) and its two mutants (CBD-I, lacking the integrin recognition sequence Arg-Gly-Asp from wtCBD and CBD-II, missing the synergistic regions). The ligand-binding assay showed that CBD-I and CBD-II bind to the receptor, although the binding ability of the former was weaker than that of the latter. The affinity of pCBD to the receptor was much higher than the two mutants. The cell adhesion assay also revealed that cells were able to attach and spread on CBD-I to the same extent as on CBD-II, although the extent of spreading on the two mutant polypeptides was less than 4.1% of pCBD or wtCBD. On the other hand, beta 1-dependent cell spreading on CBD-II was not inhibited by the monoclonal antibody specific for the alpha 5 subunit, while that on CBD-I, wtCBD, or pCBD was inhibited by the same antibody. The present study suggests that the alpha 5 subunit does not participate in direct binding to the Arg-Gly-Asp site in CBD when cells adhere to FN through the integrin alpha 5 beta 1, but that it is involved in the interaction with the synergistic regions of CBD, which then enhances the binding of the beta 1 subunit to the Arg-Gly-Asp sequence containing CBD.

Authors+Show Affiliations

Tsukuba Laboratory, Yoshizato Morphomatrix Project, ERATO, JRDC, Japan.No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

7529190

Citation

Obara, M, and K Yoshizato. "Possible Involvement of the Interaction of the Alpha 5 Subunit of Alpha 5 Beta 1 Integrin With the Synergistic Region of the Central Cell-binding Domain of Fibronectin in Cells to Fibronectin Binding." Experimental Cell Research, vol. 216, no. 1, 1995, pp. 273-6.
Obara M, Yoshizato K. Possible involvement of the interaction of the alpha 5 subunit of alpha 5 beta 1 integrin with the synergistic region of the central cell-binding domain of fibronectin in cells to fibronectin binding. Exp Cell Res. 1995;216(1):273-6.
Obara, M., & Yoshizato, K. (1995). Possible involvement of the interaction of the alpha 5 subunit of alpha 5 beta 1 integrin with the synergistic region of the central cell-binding domain of fibronectin in cells to fibronectin binding. Experimental Cell Research, 216(1), 273-6.
Obara M, Yoshizato K. Possible Involvement of the Interaction of the Alpha 5 Subunit of Alpha 5 Beta 1 Integrin With the Synergistic Region of the Central Cell-binding Domain of Fibronectin in Cells to Fibronectin Binding. Exp Cell Res. 1995;216(1):273-6. PubMed PMID: 7529190.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Possible involvement of the interaction of the alpha 5 subunit of alpha 5 beta 1 integrin with the synergistic region of the central cell-binding domain of fibronectin in cells to fibronectin binding. AU - Obara,M, AU - Yoshizato,K, PY - 1995/1/1/pubmed PY - 1995/1/1/medline PY - 1995/1/1/entrez SP - 273 EP - 6 JF - Experimental cell research JO - Exp Cell Res VL - 216 IS - 1 N2 - The interaction between the central cell-binding domain (CBD) of fibronectin (FN) and its receptor integrin alpha 5 beta 1 was analyzed by both ligand-binding and cell adhesion assays. The ligands used were a CBD fragment (pCBD) of human plasma fibronectin and its recombinant versions including wild type CBD (wtCBD) and its two mutants (CBD-I, lacking the integrin recognition sequence Arg-Gly-Asp from wtCBD and CBD-II, missing the synergistic regions). The ligand-binding assay showed that CBD-I and CBD-II bind to the receptor, although the binding ability of the former was weaker than that of the latter. The affinity of pCBD to the receptor was much higher than the two mutants. The cell adhesion assay also revealed that cells were able to attach and spread on CBD-I to the same extent as on CBD-II, although the extent of spreading on the two mutant polypeptides was less than 4.1% of pCBD or wtCBD. On the other hand, beta 1-dependent cell spreading on CBD-II was not inhibited by the monoclonal antibody specific for the alpha 5 subunit, while that on CBD-I, wtCBD, or pCBD was inhibited by the same antibody. The present study suggests that the alpha 5 subunit does not participate in direct binding to the Arg-Gly-Asp site in CBD when cells adhere to FN through the integrin alpha 5 beta 1, but that it is involved in the interaction with the synergistic regions of CBD, which then enhances the binding of the beta 1 subunit to the Arg-Gly-Asp sequence containing CBD. SN - 0014-4827 UR - https://www.unboundmedicine.com/medline/citation/7529190/Possible_involvement_of_the_interaction_of_the_alpha_5_subunit_of_alpha_5_beta_1_integrin_with_the_synergistic_region_of_the_central_cell_binding_domain_of_fibronectin_in_cells_to_fibronectin_binding_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0014-4827(85)71033-6 DB - PRIME DP - Unbound Medicine ER -